IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.732
-0.032 (-1.81%)
Sep 2, 2026, 5:29 PM CET
IRLAB Therapeutics AB Earnings Call Transcripts
Fiscal Year 2024
-
The company is advancing a robust pipeline for Parkinson's and CNS disorders, leveraging a proprietary AI-driven platform for higher success rates and lower costs. Lead assets are progressing toward late-stage trials, with active partnering and financing efforts underway.